Metabolites of intestinal fora can be used as diagnostic and progressive markers for mild cognitive impairment
PurposeThe aim of the work was to analyze the metabolites of the intestinal microbiota from the patients with mild cognitive impairment (MCI) and progressive MCI due to Alzheimer’s disease (AD).MethodTwo cohorts were established. The first one included 87 subjects with 30 healthy controls (NC), 22 p...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-02-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2024.1351523/full |